Hydrochlorothiazide
Drug ingredientActive ShortageCAS 58-93-5
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293590 · basket
These shares come from HS customs code 293590, which covers 182 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Portugal
- Spain
- Italy
- Austria
- Israel
- Hungary
- Canada
- South Korea
- Netherlands
- Finland
- Poland
- Indonesia
- Ukraine
- Mexico
- South Africa
- Croatia
- Greece
- Taiwan
- Hong Kong
102 FDA-registered drug labelers
Why It Matters
Appears in 43 drug and cosmetic product listings (FDA).
- •valsartan and hydrochlorothiazide
- •Olmesartan Medoxomil and Hydrochlorothiazide
- •Losartan Potassium and Hydrochlorothiazide
- •Spironolactone and Hydrochlorothiazide
- •Hydrochlorothiazide
- •Lisinopril and Hydrochlorothiazide
- •Bisoprolol Fumarate and Hydrochlorothiazide
- •benazepril hydrochloride and hydrochlorothiazide
Show all 43
- •Micardis HCT
- •Benicar HCT
- •Olmesartan medoxomil Amlodipine and Hydrochlorothiazide
- •Telmisartan and Hydrochlorothiazide
- •Irbesartan AND Hydrochlorothiazide
- •Triamterene and Hydrochlorothiazide
- •Amlodipine, Valsartan, Hydrochlorothiazide
- •Zestoretic
- •Quinapril and Hydrochlorothiazide
- •Candesartan Cilexetil and Hydrochlorothiazide
- •Lisinopril/HCTZ
- •Exforge HCT
- •Captopril AND Hydrochlorothiazide
- •amlodipine,valsartan and hydrochlorothiazide
- •Vaseretic
- •olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
- •Enalapril Maleate and Hydrochlorothiazide
- •olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
- •Hyzaar
- •Diovan HCT
- •Lotensin HCT
- •Quinapril HCL and Hydrochlorothiazide
- •Atacand HCT
- •Inzirqo
- •Tribenzor
- •Metoprolol Tartrate and Hydrochlorothiazide
- •Avalide
- •Fosinopril Sodium and Hydrochlorothiazide
- •Quinapril Hydrochloride/Hydrochlorothiazide
- •GUNA-DIUR
- •olmesartan medoxomil-hydrochlorothiazide
- •Quinapril and Hydrochlorothiazide 20/25
- •Quinapril and Hydrochlorothiazide 10/12.5
- •Quinapril and Hydrochlorothiazide 20/12.5
- •Amiloride Hydrochloride and Hydrochlorothiazide
- to be discontinued
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet
Shortage listed since June 13, 2025
- Current shortage
Quinapril/Hydrochlorothiazide Tablet
Shortage listed since January 19, 2023
Manufacturer reports: 1 unavailable, 1 available
- to be discontinued
Hydrochlorothiazide; Quinapril Hydrochloride Tablet
Shortage listed since October 1, 2025
- to be discontinued
Hydrochlorothiazide Capsule
Shortage listed since November 19, 2025
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
27 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| AA BLOCKS | United States | $0.71 | 500 g | 99% |
| AK Scientific, Inc. | United States | $0.97 | 500 g | 98% |
| Combi-Blocks, Inc. | United States | $1.00 | 100 g | 98% |
| AK Scientific Specialized | United States | $1.03 | 100 g | 95% |
| Biopharma PEG Scientific Inc. | United States | $1.76 | 100 g | 99% |
| Apollo Scientific US | United Kingdom | $1.98 | 100 g | 98% |
| Apexbio Technology LLC | United States | $3.04 | 25 g | 99.64% |
| Sigma-Aldrich (Rush Stock) | Germany | $6.15 | 100 g | — |
| Sigma-Aldrich | Germany | $6.15 | 100 g | — |
| MedChemExpress MCE | Sweden | $11.98 | 10 g | 99.46% |
| Cayman Europe | Estonia | $19.99 | 5 g | 98% |
| MedKoo Biosciences, Inc | United States | $26.00 | 25 g | 98% |
| CliniSciences GmbH | Switzerland | $32.25 | 1 g | 99% |
| Molnova | China | $74.00 | 500 mg | 99% |
| Labotest KG | Germany | $217.80 | 5000 mg | 90% |
| TargetMol Chemicals | China → United States | $580.00 | 50 mg | 99.9% |
| Specs | Netherlands | $1694.00 | 20 mg | 90% |
| Otava, Ltd. | Ukraine | $2280.00 | 50 mg | 95% |
| Maybridge, Ltd. | United Kingdom | $2414.30 | 100 mg | 90% |
| Otava, Ltd. (2 weeks) | Ukraine | $2724.00 | 50 mg | 90% |
| Key Organics Ltd. | United Kingdom | $2740.00 | 50 mg | 95% |
| Princeton BioMolecular Research (SC) | United States | $2900.00 | 100 mg | 90% |
| Vitas M Chemical Limited | Hong Kong | $3170.00 | 100 mg | 90% |
| Life Chemicals Inc. | Ukraine → Canada | $3466.67 | 75 mg | 90% |
| Asinex | Netherlands | $6461.40 | 100 mg | 90% |
| ChemDiv, Inc. | United States | $11300.00 | 10 mg | 90% |
| TimTec, LLC | United States | $16000.00 | 30 mg | 90% |
Chemical Identity
Data Sources
- PubChem · compound 3639Retrieved 2026-04-07
- EPA TSCA InventoryRetrieved 2026-04-24
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Hydrochlorothiazide (CAS 58-93-5) https://chemicalindependence.com/chemical/58-93-5/ PubChem: 3639. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/3639 EPA TSCA Inventory: CAS 58-93-5. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 58-93-5. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293590 for CAS 58-93-5. Reporting year: 2024. https://usatrade.census.gov/